할로아세틸시코닌 유도체의 합성 및 항암성 평가

Haloacetylshikonin Derivatives : Synthesis and Evaluation of Antitumor Activity

  • 정상국 (중국 연변대학교 약학대학) ;
  • 김광수 (중국 연변대학교 약학대학) ;
  • 송규용 (충남대학교 약학대학) ;
  • 조훈 (건일약품 주식회사) ;
  • 안병준 (충남대학교 약학대학)
  • 발행 : 1998.04.01

초록

The secondary hydroxy group at side chain of shikonin structure was selectively acylated with various haloacetic acids in presence of dicyclohexylcarbodiimide and 4-dimethylamin opyridine to produce haloacetylshikonin derivatives. The cytotoxicity of monohaloacetylshikonin derivatives against L1210 cells increased in the following order; monochloroacetylshikonin ($ED_{50}$, 0.142${\mu}$g/ml) > monobromoacetylshikonin ($ED_{50}$. 0.158${\mu}$g/ml) > monoiodoacetylshikonin ($ED_{50}$, 0.173${\mu}$g/ml). Introduction of larger halogen atoms decreased the cytotoxic activity, presumably due to steric hinderance. The cytotoxicity of chloroacetylshikonin derivatives was dependent on the number of chlorine atom, thus increasing in the following order; trichloroacetylshikonin (0.032${\mu}$g/ml) > dichloroacetylshikonin (0.059${\mu}$g/ml) > monochloroacetylshikonin ($ED_{50}$, 0.142${\mu}$g/ml). Thus, the electron withdrawing effect seems to be important for the cytotoxicity of chloroacetylshikonin derivatives. Consistent with the above, dichloroacetylshikonin (T/C. 182%) and trifluoroacetylshikonin (195%) showed higher T/C values than monochloroacetyl-(T/C, 122%), monobromoacetyl-(T/C, 154%) and monoiodoacetylshikonin (T/C, 117%) derivatives. Haloacetylshikonin derivatives showing lower cytoxic activities against L1210 cells exhibited lower T/C values. It seems that there is a relationship between the cytoxicity of haloacetylshikonin and their antitumor activity.

키워드

참고문헌

  1. Yakhak Hoeji v.34 no.4 Antitumor effect acetylshikonin and some synthesized naphthazarins on L1210 and S-180 systems Kim, H.;Ahn, B.Z.
  2. Med. Chem. v.8 no.6 ylshikonin analogues: Synthesis and inhibition of DNA topo isomerase Ⅰ Ahn, B.Z.;Baik, K.U.;Kweon, G.R.;Lim, K.;Hwang, B.D.
  3. Cancer. Chemother. Rep. v.2 Cytotoxicity assay with L1210 cell in vitro and KB cells in vitro ayer, P.S.;Himnelfarb, P.;Watt, G.L.
  4. Arch. Pharm. Res. v.19 no.5 Antitumor activity of arylacetylshikonin analogure Kim, S.H.;Song, G.Y.;Jin, G.Z.;Ahn, B.Z.
  5. Korean J. of Med. Chem. v.6 Cytotoxicity of acylshikonin analogues against L1210 cells and their antitumor activity aginst sarcoma tumors Ahn, B.Z.;Song, G.Y.;Baik, K.U.;Sok, D.E.
  6. Current Pharmaceutical design v.2 Michael acceptors as a tool for anticancer drug design Ahn, B.Z.;Sok, D.E.